Should you buy American CryoStem Corporation stock? (Other OTC:CRYO). Let's see how it does in our automated value investing analysis system.
Estimate how long you need to hold American CryoStem Corporation to reach your target.
| Advantages | Disadvantages | Neutral |
|---|---|---|
| None. |
|
|
| CRYO Price (American CryoStem Corporation stock price per share) |
$0.12 | |
| PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 100% lower than other Biotechnology stocks | |
| Free Cash Flow Jitter | 45% |
Based on our analysis, we believe that you should not buy American CryoStem Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does American CryoStem Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to CRYO: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
What is Liquidity in Stocks and Financial Instruments?
What Happened to the Stock Market Today?
Should You Invest in Gold or Silver?
Is There a Secret Formula to Pick Good Stocks?
What is the Difference Between Trading Stocks and Investing?
Stock Brokers and Investment Brokers
What Does a Trump Administration Mean for the Stock Market?